Aptevo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.

CEO

Marvin L. White

CEOMarvin L. White

Employees

Employees42

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2016

Founded2016

Employees

Employees42

APVO Key Statistics

Market cap

6.48M

Market cap6.48M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

24.46M

Average volume24.46M

High today

$2.73

High today$2.73

Low today

$1.77

Low today$1.77

Open price

$2.52

Open price$2.52

Volume

115.35M

Volume115.35M

52 Week high

$381.10

52 Week high$381.10

52 Week low

$1.32

52 Week low$1.32

APVO News

Benzinga 23h

Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results

Aptevo Therapeutics Inc. APVO jumped 46.10% to $2.06 during after-hours trading on Wednesday following breakthrough clinical results demonstrating its drug’s po...

TipRanks 2d

Aptevo Announces 100% Remission in AML Trial

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 3d

Why Is Aptevo Therapeutics Stock Up 50% Today?

Aptevo Therapeutics (APVO) stock rocketed higher on Tuesday after the biotechnology company released results from its Phase 1b/2 RAINIER trial of mipletamig. Mi...

More APVO News

TipRanks 3d

Aptevo says mipletamig deliver 100% remission rate in RAINIER cohort 3

Aptevo Therapeutics (APVO) announced a 100% remission rate in Cohort 3 of its Phase 1b/2 RAINIER trial evaluating mipletamig, the Company’s CD123 x CD3 bispecif...

People also own

Based on the portfolios of people who own APVO. This list is generated using Robinhood data, and it’s not a recommendation.

Bollinger Innovations

Tonix Pharmaceuticals